-
EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals
-
Resolution: Answered
-
Moderate
-
None
-
None
-
-
CMS0104v11
A patient was discharged on Dabigatran Etexilate 150mg plpk. When i look at the Antithrombotic Therapy value set (for CY 2023) i only see "Dabigatran Etexilate 150mg Oral Capsule" - I do not see anything for "plpk" - which is pellet pack. Can you clarify why plpk are not included in this measure? This patient is showing up as an outlier for STK-2 - Thanks!